Serum Resistin and Risk of Type 2 Diabetes Circulating Levels of Resistin and Risk of Type 2 Diabetes in Men and Women: Results from Two Prospective Cohorts Short running title: Serum Resistin and Risk of Type 2 Diabetes

1 Program on Genomics and Nutrition, Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA; Division of Preventive Medicine, Department of Medicine, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard School of Public Health, Boston, MA; Department of Nutrition, Harvard School of Public Health, Boston, MA; Department of Physiological Science, University of California, Los Angeles, CA; Department of Laboratory Medicine, Children’s Hospital and Harvard Medical School, Boston, MA; Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA; Division of Aging, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; 9 Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA.